About Advanov Pharma
Advanov Pharma is a Healthcare company based in Ahmedabad (India). Pharmaceutical product development and distribution are focused on advanced drug delivery systems in global markets. Its Indian entity Advanov Pharma Private Limited reported revenue of ₹22.68 Cr. Advanov Pharma offers products and services including Enoxaparin Sodium Injection and Amphotericin B Injection. Its focus areas include Pharmaceuticals, Drug Manufacturing, Injectables and Medical Devices.
Company details
Advanov Pharma is recognized as a global pharmaceutical entity that emphasizes the development of advanced, novel, and innovative drug delivery systems. Formulation development and regulatory support are provided through WHO-GMP, EU-GMP, and USFDA compliant manufacturing partners. Operations are extended across Latin America, CIS, Asia, Africa, and India, with a commitment to high-quality standards in healthcare offerings. An exceptionally qualified team and approved production facilities are utilized to enrich lives through efficient distribution channels, while core values center on adding value and ensuring global reach for products.
- Headquarters Ahmedabad, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn X Facebook
- Legal Name Advanov Pharma Pvt. Ltd
- Date of Incorporation 12 Jun, 2017
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹22.68 Cr
FY 2024 · +107% YoY
- Net Profit₹86 Lakh
FY 2024 · 4% margin
- EBITDA₹1.74 Cr
FY 2024 · 8% margin
Associated legal entities of Advanov Pharma
Advanov Pharma operates through Advanov Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Advanov Pharma Private Limited CIN U74999GJ2017PTC097840 | Active | 12 Jun 2017 | Ahmedabad, Gujarat | ₹22.7 Cr | 2 | View details |
Products & Services of Advanov Pharma
Advanov Pharma offers a comprehensive portfolio of products and services, including Enoxaparin Sodium Injection and Amphotericin B Injection.
Enoxaparin Sodium Injection is manufactured for therapeutic uses in critical care settings, with formulations developed under certified standards.
Amphotericin B Injection is produced as a lyophilized or liposomal form for treatment purposes, ensuring compliance with regulatory requirements.
Board of directors of Advanov Pharma Private Limited (Advanov Pharma)
Advanov Pharma Private Limited is the primary company behind Advanov Pharma. The board of Advanov Pharma Private Limited currently have 2 directors; the longest-serving is Hemalkumar Rashmikant Shah, appointed in 2018. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hemalkumar Rashmikant Shah DIN 08110574 | Managing Director | 18 Apr 2018 | 8 yrs 6 mo | Advanov Pharma Private Limited |
| Gayatriben Hemalbhai Shah DIN 09436672 | Director | 06 Feb 2023 | 3 yrs 8 mo | Advanov Pharma Private Limited |
Financials of Advanov Pharma
Figures of Advanov Pharma Private Limited, the primary company behind Advanov Pharma, for FY 2024. Revenue was ₹22.68 Cr (+107% year on year). Net profit was ₹86 Lakh (4% margin). EBITDA was ₹1.74 Cr (8% margin). Revenue has grown at a compounded annual rate of +12% over three years and +85% over five years.
- ₹22.68 CrRevenue · FY 2024 · +107% YoY
- ₹86 LakhNet profit · 4% margin
- ₹1.74 CrEBITDA · 8% margin
- ₹1 LakhPaid-up capital
- +12%Revenue CAGR, 3 years
- +85%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Advanov Pharma Private Limited are on its company page.
Detailed financial statements for Advanov Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Advanov Pharma
Advanov Pharma is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
The primary company behind Advanov Pharma, Advanov Pharma Private Limited, reported revenue of ₹22.68 Cr for FY 2024, up 107% year on year.
Advanov Pharma is recognized as a global pharmaceutical entity that emphasizes the development of advanced, novel, and innovative drug delivery systems. Formulation development and regulatory support are provided through WHO-GMP, EU-GMP, and USFDA compliant manufacturing partners. Operations are extended across Latin America, CIS, Asia, Africa, and India, with a commitment to high-quality standards in healthcare offerings. An exceptionally qualified team and approved production facilities are utilized to enrich lives through efficient distribution channels, while core values center on adding value and ensuring global reach for products.
Advanov Pharma offers Enoxaparin Sodium Injection and Amphotericin B Injection.
Advanov Pharma operates through Advanov Pharma Private Limited.
The legal entities of Advanov Pharma currently have 2 directors, including Hemalkumar Rashmikant Shah, Gayatriben Hemalbhai Shah.